NCT07191730 2026-03-19
ML-CardioTox
University Hospital, Caen
Recruiting
Clinical Trials
26 trialsNCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT05507879 2026-02-10
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
Mayo Clinic
Recruiting
NCT06595147 2026-01-08
BE-FITTER
University of Alberta
Phase NA Recruiting
NCT07245069 2025-11-24
Alpaca
University Medical Centre Ljubljana
Phase 2 Recruiting
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT06831994 2025-06-29
Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity
Universitätsklinikum Hamburg-Eppendorf
Phase NA Recruiting
NCT06930521 2025-04-16
JUSTIFY
Women's College Hospital
Phase NA Not yet recruiting
NCT04680442 2025-04-06
SCHOLAR-2
Population Health Research Institute
Phase 2 Recruiting
NCT05465031 2025-03-14
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
Phase 4 Recruiting
NCT05851053 2024-05-29
BLOC-II
University Medical Center Groningen
Recruiting
NCT05921279 2023-07-25
UCARE
National University of Ireland, Galway, Ireland
Recruiting
NCT05892146 2023-06-07
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
Phase NA Unknown
NCT05732051 2023-03-17
NARNIA
University Hospital, Akershus
Phase 2 Recruiting
NCT03850171 2023-02-27
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
Phase NA Terminated
NCT00247975 2022-08-16
Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
Ottawa Heart Institute Research Corporation
Phase 2/3 Terminated
NCT05298072 2022-03-28
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
University Hospital, Essen
Unknown
NCT03505164 2021-04-27
The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor
Rush University Medical Center
Completed
NCT02907021 2020-10-09
SCHOLAR
Population Health Research Institute
Phase 1 Completed
NCT03155802 2019-11-01
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
Stony Brook University
Unknown
NCT02440620 2019-05-01
CaTOB
Odense University Hospital
Completed
NCT01724450 2018-02-05
Ceccy
University of Sao Paulo
Phase 3 Completed
NCT01016886 2016-02-09
MANTICORE
AHS Cancer Control Alberta
Phase 1/2 Unknown
NCT01105923 2015-02-02
MAPLE
Brigham and Women's Hospital
Phase NA Unknown
NCT00858039 2014-11-05
CATS
Royal Prince Alfred Hospital, Sydney, Australia
Completed
NCT01434134 2014-10-22
PRADA
University Hospital, Akershus
Phase 2 Completed